Freedom Capital Downgrades AtriCure Inc. (ATRC) to Hold

October 2, 2026 6:12 AM

Freedom Capital analyst Keith Hinton downgraded AtriCure Inc. (NASDAQ: ATRC) from Buy to Hold with a price target of $57.00 ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found